Mechanisms of transfusion-linked parasite infection

Wendel, 1994, Current concepts on transmission of bacteriae and parasites by blood components, Vox Sang, 67s3, 161, 10.1111/j.1423-0410.1994.tb04568.x Blachman, 2006, The continuing risk of transfusion-transmitted infections, N. Engl. J. Med., 355, 1303, 10.1056/NEJMp068178 Reesink, 2004, Are current measures to prevent transfusion-associated protozoa infections sufficient?, Vox Sang., 87, 125, 10.1111/j.0042-9007.2004.00549.x Garraud, 2005, Parasites and blood transfusion: Immunity to these parasites and how is the risk of transmission from donor to receiver covered?, 401 Frydas, 2002, Some aspects of parasitology and immunology in general medicine, J Immunopathol Pharmacol, 3, 165, 10.1177/039463200201500302 Paul, 2004, Mosquitoes and transmission of malaria parasites—not just vectors, Malaria J, 3, 39, 10.1186/1475-2875-3-39 http://www.brown.edu/Courses/Bio_160/Projects1999/malaria/ldpg.htmml#BM40. Kitchen, 2006, Malaria and blood transfusion, Vox Sang., 90, 77, 10.1111/j.1423-0410.2006.00733.x Riley, 2006, Regulating immunity to malaria, Parasite Immunol., 28, 35, 10.1111/j.1365-3024.2006.00775.x Stevenson, 2004, Innate immunity to malaria, Nat. Rev. Immunol., 4, 169, 10.1038/nri1311 Meylan, 2006, Intracellular pattern recognition receptors in the host response, Nature, 442, 39, 10.1038/nature04946 Riley, 2006, Notice of redundant publication: plasma levels of interleukin-18 and interleukin-12 in Plasmodium falciparum malaria, Parasite Immunol., 28, 231, 10.1111/j.1365-3024.2006.00880.x Tongren, 2006, Target antigen, age and duration of antigen exposure independently regulate immunoglobulin G subclass switching in malaria, Infect. Immun., 74, 257, 10.1128/IAI.74.1.257-264.2006 Garraud, 2002, Regulation of antigen-specific immunoglobulin G subclasses in response to conserved and polymorphic Plasmodium falciparum antigens in in vitro model, Infect. Immun., 70, 2820, 10.1128/IAI.70.6.2820-2827.2002 Collins, 1999, A retrospective examination of sporozoite- and merozoite-induced infections with Plasmodium falciparum: development of parasitologic and clinical immunity during primary infection, Am J Trop Med Hyg, 61s1, 4, 10.4269/tropmed.1999.61-04 Collins, 1999, A retrospective examination of sporozoite- and merozoite-induced infections with Plasmodium falciparum: development of parasitologic and clinical immunity during secondary infection, Am J Trop Med Hyg, 61s1, 20, 10.4269/tropmed.1999.61-020 Collins, 1999, A retrospective examination of sporozoite- and merozoite-induced infections with Plasmodium falciparum in patients previously infected with heterologous species of Plasmodium: effect on development on parasitologic and clinical immunity, Am J Trop Med Hyg, 61s1, 36, 10.4269/tropmed.1999.61-036 Molineaux, 2002, Malaria therapy reinoculation data suggest individual variation of an innate immune response and independent acquisition of antiparasitic and antitoxic immunities, Trans. R. Soc. Trop. Med. Hyg., 96, 205, 10.1016/S0035-9203(02)90308-1 Urban, 2006, Malaria pigment paralyzes dendritic cells, J. Biol., 12, 4, 10.1186/jbiol37 Machouart, 2006, Development of a PCR assay followed by nonradioactive hybridization using oligonucleotides covalently bound to CovaLink NH microwells for detection of four Plasmodium species in blood samples from humans, J. Clin. Microbiol., 44, 3279, 10.1128/JCM.00014-06 Van der heyde, 2006, A unified hypothesis for the genesis of cerebral malaria: sequestration, inflammation, and hemostasis leading to microcirculatory dysfunction, Trends Parasitol., 10.1016/j.pt.2006.09.002 Greenwood, 2005, Malaria, Lancet, 365, 1487, 10.1016/S0140-6736(05)66420-3 Garraud, 2004, Post-transfusion malaria: is the risk irreconciliable with biological silence? (in French), Transfus. Clin. Biol., 11, 87, 10.1016/j.tracli.2004.02.003 Garraud, 2003, Malaria-specific antibody subclasses in immune individuals: a key source of information for vaccine design, Trends Immunol., 24, 30, 10.1016/S1471-4906(02)00012-1 Garraud, 2005, Post-transfusion parasite transmission: do the present controls fit with the EU directive? (in French), Transfus. Clin. Biol., 12, 275, 10.1016/j.tracli.2005.05.001 Reesink, 2005, European strategies against the parasite transfusion risk, Transfus. Clin. Biol., 12, 1, 10.1016/j.tracli.2004.12.001 Golgher, 2004, Innate and acquired immunity in the pathogenesis of Chagas disease, Autoimmunity, 37, 399, 10.1080/08916930410001713115 Teixeira, 2006, Chemokines in host–parasite interactions in leishmaniasis, Trends Parasitol., 32, 32, 10.1016/j.pt.2005.11.010 Cazenave, 2006, Pathogen inactivation in labile blood products: transfusion safety and economic impact (in French), Bull. Acad. Natl. Med., 190, 169